LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer

PURPOSE: We report that the reactivity of a novel monoclonal antibody LpMab-23 for human cancer-type podoplanin (PDPN) is a predictor for a poor prognosis of tongue cancer. PATIENTS AND METHODS: The association between LpMab-23-recognizing cancer-type PDPN expression and clinical/pathological featur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Miyazaki, Akihiro, Nakai, Hiromi, Sonoda, Tomoko, Hirohashi, Yoshihiko, Kaneko, Mika K., Kato, Yukinari, Sawa, Yoshihiko, Hiratsuka, Hiroyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940393/
https://ncbi.nlm.nih.gov/pubmed/29765527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24986
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados